{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T05:10:35Z","timestamp":1780463435046,"version":"3.54.1"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"suppl_1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1093\/infdis\/jit838","type":"journal-article","created":{"date-parts":[[2014,10,14]],"date-time":"2014-10-14T12:59:57Z","timestamp":1413291597000},"page":"S485-S497","source":"Crossref","is-referenced-by-count":48,"title":["Modeling the Potential Role of Inactivated Poliovirus Vaccine to Manage the Risks of Oral Poliovirus Vaccine Cessation"],"prefix":"10.1093","volume":"210","author":[{"given":"Radboud J.","family":"Duintjer Tebbens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly M.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,11,1]]},"reference":[{"key":"key\n\t\t\t\t20170702114458_JIT838C1","volume-title":"Cessation of Routine Oral Polio Vaccine (OPV) use after Global Polio Eradication: framework for national policy makers in OPV-using countries","author":"World Health Organization","year":"2005"},{"key":"key\n\t\t\t\t20170702114458_JIT838C2","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1539-6924.2006.00827.x","article-title":"Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication","volume":"26","author":"Duintjer Tebbens","year":"2006","journal-title":"Risk Anal"},{"key":"key\n\t\t\t\t20170702114458_JIT838C3","first-page":"95","article-title":"Transmission of wild poliovirus type 2\u2014 Apparent global interruption","volume":"76","author":"World Health Organization","year":"2001","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t20170702114458_JIT838C4","article-title":"Global Polio Eradication Initiative \u2014List of wild poliovirus by country","author":"World Health Organization"},{"key":"key\n\t\t\t\t20170702114458_JIT838C5","author":"World Health Organization"},{"key":"key\n\t\t\t\t20170702114458_JIT838C6","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1056\/NEJMoa1202541","article-title":"Priming after a fractional dose of inactivated poliovirus vaccine","volume":"368","author":"Resik","year":"2013","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170702114458_JIT838C7","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/risa.12044","article-title":"Characterizing poliovirus transmission and evolution: insights from modeling experiences with wild and vaccine-related polioviruses","volume":"23","author":"Duintjer Tebbens","year":"2013","journal-title":"Risk Anal"},{"key":"key\n\t\t\t\t20170702114458_JIT838C8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2334-14-45","article-title":"The potential impact of expanding target age groups for polio immunization campaigns","volume":"14","author":"Duintjer Tebbens","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"suppl 1","key":"key\n\t\t\t\t20170702114458_JIT838C9","doi-asserted-by":"crossref","first-page":"S475","DOI":"10.1093\/infdis\/jit845","article-title":"Modeling the dynamics of oral poliovirus vaccine cessation","volume":"210","author":"Thompson","year":"2014","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170702114458_JIT838C10","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1539-6924.2012.01864.x","article-title":"Expert review on poliovirus immunity and transmission","volume":"33","author":"Duintjer Tebbens","year":"2013","journal-title":"Risk Anal"},{"key":"key\n\t\t\t\t20170702114458_JIT838C11","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/risa.12031","article-title":"Review and assessment of poliovirus immunity and transmission: synthesis of knowledge gaps and identification of research needs","volume":"33","author":"Duintjer Tebbens","year":"2013","journal-title":"Risk Anal"},{"key":"key\n\t\t\t\t20170702114458_JIT838C12","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1539-6924.2012.01891.x","article-title":"Modeling population immunity to support efforts to end the transmission of live polioviruses","volume":"33","author":"Thompson","year":"2013","journal-title":"Risk Anal"},{"key":"key\n\t\t\t\t20170702114458_JIT838C13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/oxfordjournals.aje.a120717","article-title":"Studies of the immunogenicity, communicability and genetic stability of oral poliovaccine administered during the winter","volume":"86","author":"Benyesh-Melnick","year":"1967","journal-title":"Am J Epidemiol"},{"key":"key\n\t\t\t\t20170702114458_JIT838C14","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1001\/jama.1996.03530450029028","article-title":"Seroprevalence of antibody against poliovirus in inner-city preschool children","volume":"275","author":"Chen","year":"1996","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170702114458_JIT838C15","first-page":"221","article-title":"Lesson from Cuba: mass campaign administration of trivalent oral poliovirus vaccine and seroprevalence of poliovirus neutralizing antibodies","volume":"72","author":"M\u00e1s Lago","year":"1994","journal-title":"Bull World Health Organ"},{"key":"key\n\t\t\t\t20170702114458_JIT838C16","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.292.14.1696","article-title":"Vaccine policy changes and epidemiology of poliomyelitis in the United States","volume":"292","author":"Alexander","year":"2004","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170702114458_JIT838C17","first-page":"210","article-title":"Vaccine-associated paralytic poliomyelitis in India during 1999: decreased risk despite massive use of oral polio vaccine","volume":"80","author":"Kohler","year":"2002","journal-title":"Bull World Health Organ"},{"key":"key\n\t\t\t\t20170702114458_JIT838C18","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.micro.58.030603.123625","article-title":"Vaccine-derived polioviruses and the endgame strategy for global polio eradication","volume":"59","author":"Kew","year":"2005","journal-title":"Ann Rev Microbiol"},{"key":"key\n\t\t\t\t20170702114458_JIT838C19","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1126\/science.1068284","article-title":"Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus","volume":"296","author":"Kew","year":"2002","journal-title":"Science"},{"key":"key\n\t\t\t\t20170702114458_JIT838C20","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/risa.12022","article-title":"Review: Oral Poliovirus Vaccine Evolution and Insights Relevant to Modeling the Risks of Circulating Vaccine-Derived Polioviruses (cVDPVs)","volume":"23","author":"Duintjer Tebbens","year":"2013","journal-title":"Risk Anal"},{"key":"key\n\t\t\t\t20170702114458_JIT838C21","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/clinids\/13.5.926","article-title":"Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review","volume":"13","author":"Patriarca","year":"1991","journal-title":"Rev Infect Dis"},{"key":"key\n\t\t\t\t20170702114458_JIT838C22","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/risa.12019","article-title":"Pre-eradication vaccine policy options for poliovirus infection and disease control","volume":"33","author":"Thompson","year":"2013","journal-title":"Risk Anal"},{"key":"key\n\t\t\t\t20170702114458_JIT838C23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.coviro.2013.05.007","article-title":"Poliovirus vaccination options for achieving eradication and securing the endgame","volume":"3","author":"Estivariz","year":"2013","journal-title":"Curr Opin Virol"},{"key":"key\n\t\t\t\t20170702114458_JIT838C24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/infdis\/163.1.1","article-title":"Mucosal immunity induced by enhanced-potency inactivated and oral polio vaccines","volume":"163","author":"Onorato","year":"1991","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170702114458_JIT838C25","doi-asserted-by":"crossref","first-page":"e1002599","DOI":"10.1371\/journal.ppat.1002599","article-title":"Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge","volume":"8","author":"Hird","year":"2012","journal-title":"PLoS Pathogens"},{"issue":"suppl 1","key":"key\n\t\t\t\t20170702114458_JIT838C26","doi-asserted-by":"crossref","first-page":"S412","DOI":"10.1093\/infdis\/jit834","article-title":"Modeling strategies to increase population immunity and prevent poliovirus transmission in the high-risk area of northwest Nigeria","volume":"210","author":"Kalkowska","year":"2014","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170702114458_JIT838C27","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF00178324","article-title":"On the definition and the computation of the basic reproduction ratio R0 in models for infectious diseases in heterogeneous populations","volume":"28","author":"Diekmann","year":"1990","journal-title":"J Math Biol"},{"issue":"suppl 1","key":"key\n\t\t\t\t20170702114458_JIT838C28","doi-asserted-by":"crossref","first-page":"S398","DOI":"10.1093\/infdis\/jit844","article-title":"Modeling strategies to increase population immunity and prevent poliovirus transmission in two high-risk areas in northern India","volume":"210","author":"Kalkowska","year":"2014","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170702114458_JIT838C29","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/aje\/kwi206","article-title":"A dynamic model of poliomyelitis outbreaks: learning from the past to help inform the future","volume":"162","author":"Duintjer Tebbens","year":"2005","journal-title":"Am J Epidemiol"},{"key":"key\n\t\t\t\t20170702114458_JIT838C30","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.2105\/AJPH.2007.122192","article-title":"The risks, costs, and benefits of possible future global policies for managing polioviruses","volume":"98","author":"Thompson","year":"2008","journal-title":"Am J Public Health"},{"key":"key\n\t\t\t\t20170702114458_JIT838C31","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(94)92091-5","article-title":"Poliomyelitis outbreak in an unvaccinated community in the Netherlands, 1992\u20133","volume":"344","author":"Oostvogel","year":"1994","journal-title":"Lancet"},{"issue":"suppl 1","key":"key\n\t\t\t\t20170702114458_JIT838C32","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1093\/infdis\/175.Supplement_1.S165","article-title":"Outbreaks of paralytic poliomyelitis, 1976\u20131995","volume":"175","author":"Patriarca","year":"1997","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170702114458_JIT838C33","first-page":"173","article-title":"Limitation of fecal and pharyngeal poliovirus excretion in Salk-vaccinated children: a family study during a type 1 poliomyelitis epidemic","volume":"76","author":"Marine","year":"1962","journal-title":"Am J Hyg"},{"key":"key\n\t\t\t\t20170702114458_JIT838C34","first-page":"973","article-title":"Interrupting the transmission of wild polioviruses with vaccines: immunological considerations","volume":"72","author":"Ghendon","year":"1994","journal-title":"Bull World Health Organ"},{"key":"key\n\t\t\t\t20170702114458_JIT838C35","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1056\/NEJMoa054960","article-title":"Randomized, placebo-controlled trial of inactivated poliovirus vaccine in Cuba","volume":"356","author":"The Cuba IPV Study Collaborative Group","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170702114458_JIT838C36","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2013.18.38.20586","article-title":"Insidious reintroduction of wild poliovirus into Israel, 2013","volume":"18","author":"Anis","year":"2013","journal-title":"Euro Surveil"},{"key":"key\n\t\t\t\t20170702114458_JIT838C37","doi-asserted-by":"crossref","first-page":"S457","DOI":"10.1093\/clinids\/6.Supplement_2.S457","article-title":"Elimination of poliomyelitis in Finland","volume":"6","author":"Lapinleimu","year":"1984","journal-title":"Rev Infect Dis"},{"key":"key\n\t\t\t\t20170702114458_JIT838C38","first-page":"67","article-title":"Poliomyelitis in Des Moines, Iowa, 1959: the influence of Salk vaccination on the epidemic pattern and the spread of the virus in the community","volume":"74","author":"Chin","year":"1961","journal-title":"Am J Hyg"},{"key":"key\n\t\t\t\t20170702114458_JIT838C39","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1586\/14760584.2014.864563","article-title":"National choices related to inactivated poliovirus vaccine, innovation, and the end game of global polio eradication","volume":"13","author":"Thompson","year":"2014","journal-title":"Expert Rev Vaccines."}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/210\/suppl_1\/S485\/18083500\/jit838.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T09:50:16Z","timestamp":1503568216000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article-lookup\/doi\/10.1093\/infdis\/jit838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":39,"journal-issue":{"issue":"suppl_1","published-online":{"date-parts":[[2014,11,1]]},"published-print":{"date-parts":[[2014,11]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jit838","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11]]}}}